217 related articles for article (PubMed ID: 22682876)
1. Compensated inflammation in systemic juvenile idiopathic arthritis: role of alternatively activated macrophages.
Shimizu M; Yachie A
Cytokine; 2012 Oct; 60(1):226-32. PubMed ID: 22682876
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis.
Sakumura N; Shimizu M; Mizuta M; Inoue N; Nakagishi Y; Yachie A
Cytokine; 2018 Oct; 110():459-465. PubMed ID: 29801971
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.
Reddy VV; Myles A; Cheekatla SS; Singh S; Aggarwal A
Int J Rheum Dis; 2014 Mar; 17(3):261-7. PubMed ID: 24417800
[TBL] [Abstract][Full Text] [Related]
5. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis during tocilizumab therapy.
Irabu H; Shimizu M; Kaneko S; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Pediatr Res; 2020 Dec; 88(6):934-939. PubMed ID: 32184444
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum biomarkers for the diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
Takakura M; Shimizu M; Irabu H; Sakumura N; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Clin Immunol; 2019 Nov; 208():108252. PubMed ID: 31449879
[TBL] [Abstract][Full Text] [Related]
7. Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis.
Inoue N; Shimizu M; Tsunoda S; Kawano M; Matsumura M; Yachie A
Clin Immunol; 2016 Aug; 169():8-13. PubMed ID: 27263804
[TBL] [Abstract][Full Text] [Related]
8. Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA.
Vastert SJ; Prakken BJ
Nat Rev Rheumatol; 2014 Nov; 10(11):640-2. PubMed ID: 25201384
[TBL] [Abstract][Full Text] [Related]
9. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.
Mizuta M; Shimizu M; Irabu H; Usami M; Inoue N; Nakagishi Y; Wada T; Yachie A
Rheumatology (Oxford); 2021 Jan; 60(1):231-238. PubMed ID: 32681176
[TBL] [Abstract][Full Text] [Related]
10. Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.
Ishikawa S; Shimizu M; Ueno K; Sugimoto N; Yachie A
Cytokine; 2013 May; 62(2):272-7. PubMed ID: 23561929
[TBL] [Abstract][Full Text] [Related]
11. Serum neopterin and soluble CD163 as markers of macrophage activation in paracetamol (acetaminophen)-induced human acute liver injury.
Craig DG; Lee P; Pryde EA; Hayes PC; Simpson KJ
Aliment Pharmacol Ther; 2013 Dec; 38(11-12):1395-404. PubMed ID: 24138337
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
Nishino A; Katsumata Y; Kawasumi H; Hirahara S; Kawaguchi Y; Yamanaka H
Lupus; 2019 Jul; 28(8):986-994. PubMed ID: 31246559
[TBL] [Abstract][Full Text] [Related]
13. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome.
Mizuta M; Shimizu M; Inoue N; Nakagishi Y; Yachie A
Cytokine; 2019 Jul; 119():182-187. PubMed ID: 30952065
[TBL] [Abstract][Full Text] [Related]
15. The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis.
Takahashi A; Mori M; Naruto T; Nakajima S; Miyamae T; Imagawa T; Yokota S
Mod Rheumatol; 2009; 19(3):302-8. PubMed ID: 19255829
[TBL] [Abstract][Full Text] [Related]
16. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
[TBL] [Abstract][Full Text] [Related]
17. Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series.
Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Yachie A
Mod Rheumatol; 2017 Sep; 27(5):833-837. PubMed ID: 28094589
[TBL] [Abstract][Full Text] [Related]
18. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
[TBL] [Abstract][Full Text] [Related]
19. Serum markers of macrophage activation in pre-eclampsia: no predictive value of soluble CD163 and neopterin.
Kronborg CS; Knudsen UB; Moestrup SK; Allen J; Vittinghus E; Møller HJ
Acta Obstet Gynecol Scand; 2007; 86(9):1041-6. PubMed ID: 17712642
[TBL] [Abstract][Full Text] [Related]
20. Association of neopterin as a marker of immune system activation and juvenile rheumatoid arthritis activity.
Shady MM; Fathy HA; Ali A; Youness ER; Fathy GA
J Pediatr (Rio J); 2015; 91(4):352-7. PubMed ID: 25727025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
